The FDA approved a new, over-the-counter intranasal naloxone spray for the treatment of emergency opioid overdose. HealthDay News — The U.S. Food and Drug Administration has approved another ...
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move ...
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, ...
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine ...
Mouse and human data hint that biological differences may shape drug bioavailability in ways clinical trials often overlook ...
For decades, influenza vaccines have been judged largely by the antibodies they generate in the bloodstream, a measure that ...
Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FLUMIST® QUADRIVALENT (Influenza ...
Intranasal monoclonal antibodies (mAbs) offer a promising cost-reducing and non-invasive alternative to systemic administration. Intranasal palivizumab prevented respiratory syncytial virus (RSV) ...
The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results